Solventum Corp | SOLV - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Abbott USD 68M 26M 2026-03
Align Technology USD 16.04M 14.04M 2025-12
Baxter International USD 58M 14M 2025-09
Becton, Dickinson and Co. USD 149M 4M 2026-03
Cencora USD 78.36B 78.25B 2025-12
Dexcom USD 4.2M 500K 2025-12
Insulet USD 14.7M 5.5M 2026-03
Solventum Corp USD 14.1B 14.05B 2026-03
West Pharmaceutical Services USD 1.9M 1.7M 2026-03
Zimmer Biomet Holdings USD 68.8M 3.1M 2026-03